Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A8dcf04b-5e92-41ff-ba58-bb1d86997ac6 - samples

ABSTRACT: Dataset contains targeted sequencing data of 712 plasma cell free DNA samples and 428 white blood cell samples collected from 428 men with metastatic prostate cancer. Target capture was performed using a hydridization-based custom Roche SeqCap EZ Choice kit, designed to capture all exons of 72 prostate cancer driver genes. Cell free DNA was extracted from 10 mL blood samples. Libraries were sequenced using Illumina HiSeq 2500 or Illumina MiSeq instruments to a median coverage of 750x. 62% of samples had ctDNA fraction above 2% of total cfDNA. Note that "Dataset type" is erroneously listed as "Amplicon sequencing", because "Captured-based targeted sequencing" or "Hybridization-based targeted sequencing" were not available options in EGA at the time of submission.

PROVIDER: EGAD00001004208 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Frequent mutation of the FOXA1 untranslated region in prostate cancer

Project description:We sequenced the coding and untranslated regions of 72 prostate cancer driver genes in 712 plasma cell free DNA samples from 428 men with metastatic prostate cancer, in an effort to understand the role of untranslated region mutations in late stage prostate cancer.

| EGAS00001003113 | EGA

HP Prostate MSK-IMPACT

Project description:Primary prostate tumor samples sequenced with MSK-IMACT, a hybridization capture-based next-generation sequencing assay. Custom DNA probes were designed for targeted sequencing of all exons and selected introns of 468 genes.

2019-08-12 | PRJEB33969 | EVA

c942540d-1b1e-4de8-b6e7-37a8eb0058af - samples

Project description:This dataset consists of aligned DNA sequencing data in BAM file format from cell-free DNA and white blood cells from 24 men with metastatic prostate cancer. One cell-free DNA sample and one white blood cell sample is available for each patient, resulting in 48 total BAM files in this dataset. The sequencing was performed using a hybrid capture-based targeted panel of 73 prostate cancer driver genes.

| EGAD00001004486 | EGA

Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression

Project description:Genome-wide copy number changes were monitored using array comparative genomic hybridization (aCGH) of laser-capture microdissected prostate cancer samples spanning stages of prostate cancer progression including precursor lesions, clinically localized disease and metastatic disease. A total of 62 specific cell populations from 38 patients were profiled. Keywords: Disease state analysis using array-based comparatavie genomic hybridization

2007-07-31 | GSE8026 | GEO

Project description:Targeted digital sequencing of reference cell-free DNA samples

| PRJNA551456 | ENA

The prostate stromal transcriptome and aggressive and lethal prostate cancer

Project description:RNA sequencing (Illumina TruSeq Exome Capture) of 272 tumor-adjacent and 120 benign-adjacent macrodissected prostate stromal samples from 293 men from the Health Professionals Follow-up Study and Physicians’ Health Study.

2022-10-11 | GSE214940 | GEO

Targeted RNA sequencing for gene discovery and quantification

Project description:Due to the large size, complex splicing and wide dynamic range of eukaryotic transcriptomes, RNA sequencing samples the majority of expressed genes infrequently, resulting in sparse sequencing coverage that can hinder robust isoform assembly and quantification. Targeted RNA sequencing addresses this challenge by using oligonucleotide probes to capture selected genes or regions of interest for focused sequencing. This enhanced sequencing coverage confers sensitive gene discovery, robust transcript assembly and accurate gene quantification. Here we describe a detailed protocol for all stages of targeted RNA sequencing, from initial probe design considerations, capture of targeted genes, to final assembly and quantification of captured transcripts. Initial probe design and final analysis can take less than a day, while the central experimental capture stage requires ~7 days. Targetted RNA sequencing of long noncoding RNAs

2014-03-01 | E-GEOD-52503 | biostudies-arrayexpress

Coletti2020 - QSP model of prostate cancer immunotherapy

Project description:This model is based on the publication: Coletti R, Leonardelli L, Parolo S, Marchetti L. A QSP model of prostate cancer immunotherapy to identify effective combination therapies. Sci Rep. 2020 Jun 3;10(1):9063. doi: 10.1038/s41598-020-65590-0 Comment: Eq. 3 - no listed species "R", therefore based on Eq. 1 and 2, R_2 used instead. Eq. 12 - no listed parameter "a_Df" in Table S1, a_Dc used based on parameter description. Curation Comment: Simulations are not reproducing manuscript plots. Matlab code is available (Supplementary File 2 of the manuscript publication) but has not been tested, so would be worth reattempting model curation.

2021-09-11 | MODEL2109110002 | BioModels

Targeted RNA sequencing for gene discovery and quantification

2014-03-01 | GSE52503 | GEO

Multiplexed Chromatin Conformation Capture in Mouse Erythroid cells using Capture-C

Project description:Multiplexed Chromatin Conformation Capture in Mouse Erythroid cells , from hundreds of targeted loci, using agilent oligo capture technology and high throughput sequencing. Two erythroid Ter119+ cell replicates and a mouse ES cell control

2013-12-21 | E-GEOD-47758 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data